What happens when you take amitriptyline with st. john's wort?
Amitriptyline is a tricyclic antidepressant (TCA) used for major depression, neuropathic pain, migraine prevention, and insomnia. It works by blocking the reuptake of serotonin and norepinephrine in the brain. St. John's wort (Hypericum perforatum) is an over-the-counter herbal product widely marketed for mild depression and mood support, and it acts on many of the same neurotransmitter systems.
Combining the two creates two simultaneous problems. First, St. John's wort is one of the most potent herbal inducers of cytochrome P450 enzymes known, particularly CYP3A4, CYP2C9, and CYP2D6. Amitriptyline is metabolized by these same enzymes, so St. John's wort accelerates the breakdown of amitriptyline and drops its blood levels. Clinical pharmacokinetic studies have shown reductions in amitriptyline AUC of roughly 20 percent within two weeks of starting the herb.
Second, both substances increase serotonin signaling. Amitriptyline blocks the serotonin transporter. St. John's wort's active constituents (hyperforin, hypericin, and several flavonoids) inhibit reuptake of serotonin, norepinephrine, and dopamine and may weakly inhibit MAO. Stacking two serotonergic agents raises the risk of serotonin syndrome, a potentially life-threatening reaction.
Why is this important?
The danger of this combination is that it pushes patients in two harmful directions at once. The pharmacokinetic interaction lowers amitriptyline exposure, which can cause depressive symptoms or pain to return even though the patient is still taking the prescribed dose. Patients and clinicians may then increase the amitriptyline dose to compensate, only to have the herb stopped weeks later when CYP enzyme activity reverts to baseline. The result is a sudden surge in amitriptyline levels and a high risk of cardiac arrhythmia, sedation, or anticholinergic toxicity.
Meanwhile, the pharmacodynamic serotonergic stacking can produce serotonin syndrome at any time during co-administration. Symptoms include agitation, confusion, hallucinations, fever, sweating, shivering, rapid heart rate, dilated pupils, muscle rigidity, hyperreflexia, tremor, incoordination, diarrhea, and seizures. Severe cases progress to high fever, rhabdomyolysis, kidney failure, coma, and death. Tricyclic antidepressants by themselves are also one of the most common causes of fatal overdose due to their narrow therapeutic index and cardiotoxic effects on sodium channels, so adding anything that destabilizes their blood levels is risky.
What should you do?
If you are taking amitriptyline, do not start St. John's wort under any circumstances without first speaking to your prescriber. If you are already on both, do not stop either abruptly: contact your healthcare provider. Stopping amitriptyline suddenly can cause withdrawal-like discontinuation symptoms, and stopping St. John's wort suddenly while still on amitriptyline can cause drug levels to spike as enzyme induction wanes over the following 1 to 2 weeks.
The safer path is to taper off St. John's wort under supervision, monitor for signs of serotonin syndrome during the transition, and recheck mood, sleep, and pain control after the herb has fully washed out. If you are taking St. John's wort for depression that has not responded to amitriptyline, ask your prescriber about evidence-based alternatives such as a dose adjustment, switching antidepressant class, or adding psychotherapy.
- Tell every prescriber and pharmacist about every supplement you take, including herbs and over-the-counter products.
- Watch for tremor, sweating, restlessness, fast heartbeat, confusion, or high fever, and seek emergency care if they appear.
- Do not assume that because a supplement is sold without a prescription, it is safe to combine with prescription medication.
- Avoid other serotonergic agents (tramadol, dextromethorphan, MAOIs, SSRIs, triptans) while taking amitriptyline.
Which specific products are affected?
Every formulation of amitriptyline is affected, including generic amitriptyline tablets and brand-name products such as Elavil and Endep. The interaction is a class effect of tricyclic antidepressants, so closely related drugs (nortriptyline, imipramine, desipramine, clomipramine, doxepin) carry the same warning.
St. John's wort is sold under many product names and standardized extracts (often standardized to 0.3 percent hypericin or 3 to 5 percent hyperforin). Common brands include Kira, Perika, Movana, and many generic store-brand products. Combination supplements marketed for mood, sleep, PMS, or stress sometimes contain St. John's wort even when it is not in the product name, so always read the full label.
The bottom line
Amitriptyline and St. John's wort are a clinically significant combination that can both reduce the effectiveness of the antidepressant and trigger serotonin syndrome. The interaction is well documented in pharmacology literature and consistently flagged as a major or contraindicated combination by drug-interaction databases. The safest course is to avoid the combination entirely and to consult a prescriber before starting, stopping, or adjusting either product.